Ayurcann Holdings Corp.

AYURF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Revenue$31,110$25,158$12,492$9,386
% Growth23.7%101.4%33.1%
Cost of Goods Sold$20,949$16,692$8,812$7,165
Gross Profit$10,161$8,465$3,680$2,221
% Margin32.7%33.6%29.5%23.7%
R&D Expenses$0$0$0$0
G&A Expenses$6,645$6,043$5,726$5,508
SG&A Expenses$12,023$10,534$8,219$5,508
Sales & Mktg Exp.$5,378$4,491$2,493$0
Other Operating Expenses$960$1,182$67$0
Operating Expenses$12,984$11,716$8,671$5,515
Operating Income-$2,823-$3,251-$5,344-$3,332
% Margin-9.1%-12.9%-42.8%-35.5%
Other Income/Exp. Net-$663-$717-$286-$38
Pre-Tax Income-$3,486-$3,968-$5,307-$3,423
Tax Expense$0$0$97-$335
Net Income-$3,486-$3,968-$5,307-$3,088
% Margin-11.2%-15.8%-42.5%-32.9%
EPS-0.013-0.022-0.035-0.026
% Growth41.5%36.7%-35.6%
EPS Diluted-0.013-0.022-0.035-0.026
Weighted Avg Shares Out194,704177,398150,124118,512
Weighted Avg Shares Out Dil194,704177,398150,124118,512
Supplemental Information
Interest Income$0$0$0$0
Interest Expense$487$717$30$91
Depreciation & Amortization$985$1,240$780$780
EBITDA-$1,838-$2,010-$4,145-$2,974
% Margin-5.9%-8%-33.2%-31.7%